AzTrials
AzTrials

Low Back PainEFFIBACKNCT05531201

Evaluation of the Efficacy of a Coordinated Interprofessional Care Pathway on Disability in Patients With Chronic and at Risk of Chronic Low Back Pain in Primary Care

A study testing collaboration general practitioner and physiotherapist in people with Low Back Pain, run by CNGE Conseil at 1 site in France.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Low back pain is a public health problem with major individual and socio-economic repercussions. In primary care, strong disparities are observed in the management of low back pain patients. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Low Back Pain
What is being tested?
collaboration general practitioner and physiotherapist
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
123 participants
Where
1 siteFrance
Study dates
15 Feb 2023to 13 Nov 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patients between the ages of 18 and 65
  • Patients consulting their GP for a first or new eisode of acute low back pain (more than 12 months from the previous one) with a STarT Back screening tool score greater than 3.
  • OR low back pain at risk of chronicity (presence of yellow flags, according to the recommendation of the High Health Authority (HAS) of 2019
  • OR recurrent low back pain: in the event of recurrence of low back pain within 12 months after the previous episode, then considered to be at risk of chronicity
  • OR having chronic low back pain (low back pain for more than 3 months)
  • Patients benefiting from the general social security system
  • Patients who understand and speak French fluently
  • Patients who have given their consent after having received complete information on the protocol

Who cannot join

  • Minor patients
  • Pregnant women (declared pregnancy) or immediately postpartum (up to 3 months)
  • Patients with "red flags" (serious neurological impairment, cancer, infection, fracture or inflammatory disease), according to the 2019 HAS recommendation
  • Patients referred immediately for imaging or specialist advice during the first consultation with the GP (suspicion of underlying pathology)
  • Patients with no history of acute low back pain, at low risk of chronicity (STarT Back screening tool score less than or equal to 3)
  • Patients with a contraindication to rehabilitation by physiotherapy
Show all 13Show fewer
  • Patients who have already undergone spine surgery
  • Patients with cognitive impairment
  • Patients whose life expectancy is less than 12 months
  • Patients under guardianship or curatorship, under judicial protection or safeguard of justice
  • Patients not affiliated to the general social security system
  • Patients with difficulties in understanding the French language
  • Patients with an inability to give express consent

Trial locations and contacts

1 site in 1 country.

France1 site
  • Maison de Santé Pluriprofessionnelle Universitaire

    Fontainebleau, 77300

Other trials in France

About this study

Official title: Evaluation of the Efficacy of a Coordinated Interprofessional Care Pathway on Disability in Patients With Chronic Low Back Pain and Patients at Risk of Chronic Low Back Pain in Primary Care: a Cluster Randomized Controlled Trial

Low back pain is a public health problem with major individual and socio-economic repercussions. In primary care, strong disparities are observed in the management of low back pain patients. While general practitioners (GPs) and physiotherapists appear as two essential first-line caregivers, collaboration between these professionals remains underdeveloped, most often characterized by a lack of consultation or coordination. Systematic increased interprofessional collaboration is likely to improve the results of the care pathway, by optimizing the existing care offer.

Conditions
Low Back Pain
Being tested
collaboration general practitioner and physiotherapist
Medical subject headings
Low Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • collaboration general practitioner and physiotherapistProcedure or surgery

    training general practitioner and physiotherapist

Study groups in NCT05531201
Study groupRoleWhat they receive
InterventionalExperimentalTrainig of GP and physiotherapist at collaborative coordinated care pathway
Receives: Procedure: collaboration general practitioner and physiotherapist
ControlNo interventionwithout modification of the usual follow-up

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Disability at 3 months

    Absolute change in overall Oswestry Disability Index (ODI) scale score between 0 and 3 months. Total score ranging from 0 (no functional disability) to 100 (severe functional disability).

    Measured: 3 months

Secondary outcomes (8)
  1. Disability at 12 months

    Absolute change in overall ODI scale score between 0 and 12 months. Total score ranging from 0 (no functional disability) to 100 (severe functional disability).

    Measured: 12 months

  2. Health-related quality of life at 3 months

    Absolute change of health-related quality of life by the EuroQol 5 Dimensions scale (EQ-5D) between 0 and 3 months and between 0 and 12 months

    Measured: 3 months

  3. Health-related quality of life at 12 months

    Absolute change of health-related quality of life by the EuroQol 5 Dimensions scale (EQ-5D) between 0 and 12 months

    Measured: 12 months

  4. Evaluation of the course of care: compliance

    number (%) of patients having followed the entire course of care

    Measured: 12 months

  5. Evaluation of the course of care: number of consultations

    total number of consultations with GPs and physiotherapists (PTs)

    Measured: 12 months

  6. Evaluation of the course of care: medical imaging

    total number of medical imaging related to low back during the follow up

    Measured: 12 months

  7. Evaluation of the course of care: total cost

    total cost (in euros €) of healthcare pathway in the two groups

    Measured: 12 months

  8. Evaluation of effective collaborative practices

    qualitative analysis of GP/PT collaboration using semi-structured interviews with professionals

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Sep 2022
  2. Study start15 Feb 2023
  3. Primary completion20 Jan 2026
  4. Study completion13 Nov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
123 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05531201
Sponsor's protocol ID
CNGE-2021/01
Other IDs
2021-A02432-39
Acronym
EFFIBACK
Status last verified
Feb 2026
First submitted
22 Aug 2022
Last updated
11 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing collaboration general practitioner and physiotherapist in people with Low Back Pain, run by CNGE Conseil at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 11 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Disability at 3 months (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in